OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fc-binding antibody-recruiting molecules exploit endogenous antibodies for anti-tumor immune responses
Koichi Sasaki, Minori Harada, Yoshiki Miyashita, et al.
Chemical Science (2020) Vol. 11, Iss. 12, pp. 3208-3214
Open Access | Times Cited: 23

Showing 23 citing articles:

Bioengineered nanogels for cancer immunotherapy
Xianbin Ma, Shu‐Jin Li, Yuantong Liu, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5136-5174
Closed Access | Times Cited: 131

Redirecting the host immune response to bacterial infection with antibody-recruiting molecules (ARMs)
Priscilla Dzigba, Misago D. Seth, Mallary C. Greenlee‐Wacker, et al.
Current Opinion in Chemical Biology (2025) Vol. 86, pp. 102585-102585
Closed Access | Times Cited: 1

Proximity-inducing modalities: the past, present, and future
Sameek Singh, Wenzhi Tian, Zachary C. Severance, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5485-5515
Closed Access | Times Cited: 17

Antibody‐Recruitment as a Therapeutic Strategy: A Brief History and Recent Advances
Winter Z. Charles, Cierra R. Faries, Ya’hnis T. Street, et al.
ChemBioChem (2022) Vol. 23, Iss. 16
Closed Access | Times Cited: 17

Universal endogenous antibody recruiting nanobodies capable of triggering immune effectors for targeted cancer immunotherapy
Haofei Hong, Chen Li, Liang Gong, et al.
Chemical Science (2021) Vol. 12, Iss. 12, pp. 4623-4630
Open Access | Times Cited: 23

Antibody recruiting molecules (ARMs): synthetic immunotherapeutics to fight cancer
Silvia Achilli, Nathalie Berthet, Olivier Renaudet
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 713-724
Open Access | Times Cited: 18

Chemical Synthesis of Antibody–Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy
Kun Zhou, Haofei Hong, Lin Han, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 323-332
Closed Access | Times Cited: 17

Advances and challenges in gene therapy strategies for pediatric cancer: a comprehensive update
Amir Kian Moaveni, Maryam Amiri, Behrouz Shademan, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2

Structural influence of antibody recruiting glycodendrimers (ARGs) on antitumoral cytotoxicity
Biagio Todaro, Silvia Achilli, Benjamin Liet, et al.
Biomaterials Science (2021) Vol. 9, Iss. 11, pp. 4076-4085
Open Access | Times Cited: 14

Polymeric PD1/PDL1 Bispecific Antibody Enhances Immune Checkpoint Blockade Therapy
Fuxin Xue, Xitong Ren, Chaoying Kong, et al.
Materials Today Bio (2024) Vol. 28, pp. 101239-101239
Open Access | Times Cited: 1

Reconstituting the immune killing functions and improving the pharmacokinetics of nanobodies by rhamnolipid conjugation
Yanchun Li, Dan Li, Lin Han, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 18-26
Closed Access | Times Cited: 1

Induction of ADCC by a folic acid–mAb conjugate prepared by tryptophan-selective reaction toward folate-receptor-positive cancer cells
Hiroshi Tagawa, Katsuya Maruyama, Koichi Sasaki, et al.
RSC Advances (2020) Vol. 10, Iss. 28, pp. 16727-16731
Open Access | Times Cited: 10

Fc‐Binding Antibody‐Recruiting Molecules Targeting Prostate‐Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement**
Koichi Sasaki, Minori Harada, Takuma Yoshikawa, et al.
ChemBioChem (2020) Vol. 22, Iss. 3, pp. 496-500
Open Access | Times Cited: 10

Metabolic labelling of cancer cells with glycodendrimers stimulate immune-mediated cytotoxicity
David Goyard, Peremobowei Iyanu Diriwari, Nathalie Berthet
RSC Medicinal Chemistry (2021) Vol. 13, Iss. 1, pp. 72-78
Open Access | Times Cited: 7

Synthesis and biological evaluation of a monocyclic Fc-binding antibody-recruiting molecule for cancer immunotherapy
Koichi Sasaki, Kyohei Muguruma, Rento Osawa, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 3, pp. 406-409
Open Access | Times Cited: 6

Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy
Anna Hoefges, SJ McIlwain, Amy K. Erbe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Poly(L-glutamic acid) based composites for improved dual immune checkpoint blockade therapy
Fuxin Xue, Haochen Yao, Jiali Sun, et al.
Research Square (Research Square) (2024)
Open Access

HER2 Nanobody-Poly(rhamnose) Conjugates Efficiently Recruit Anti-Rhamnose Antibodies from Serum to the Surface of HER2-Expressing Cells
Weiwei Mu, Yong Chen, Zifu Zhong, et al.
Chemistry of Materials (2024) Vol. 36, Iss. 20, pp. 10113-10124
Closed Access

Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen
Anna Hoefges, Sean McIlwain, Amy K. Erbe, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1

The effect of Fc region affinity of protein-based antibody-recruiting molecules on antibody-dependent cellular cytotoxicity
Hiroshi Tagawa, Riku Saeki, Chihaya Yamamoto, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 22860-22866
Open Access

A platform for mapping reactive cysteines within the immunopeptidome
Chenlu Zhang, Zhou Chen, Assa Magassa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access

Page 1

Scroll to top